Co-encapsulation of anti-BMP2 monoclonal antibody and mesenchymal stem cells in alginate microspheres for bone tissue engineering

Alireza Moshaverinia, Sahar Ansari, Chider Chen, Xingtian Xu, Kentaro Akiyama, Malcolm L. Snead, Homayoun H. Zadeh, Songtao Shi

Research output: Contribution to journalArticle

78 Citations (Scopus)

Abstract

Recently, it has been shown that tethered anti-BMP2 monoclonal antibodies (mAbs) can trap BMP ligands and thus provide BMP inductive signals for osteo-differentiation of progenitor cells. The objectives of this study were to: (1) develop a co-delivery system based on murine anti-BMP2 mAb-loaded alginate microspheres encapsulating human bone marrow mesenchymal stem cells (hBMMSCs); and (2) investigate osteogenic differentiation of encapsulated stem cells in alginate microspheres invitro and invivo. Alginate microspheres of 1±0.1mm diameter were fabricated with 2×106 hBMMSCs per mL of alginate. Critical-size calvarial defects (5mm diameter) were created in immune-compromised mice and alginate microspheres preloaded with anti-BMP mAb encapsulating hBMMSCs were transplanted into defect sites. Alginate microspheres pre-loaded with isotype-matched non-specific antibody were used as the negative control. After 8 weeks, micro CT and histologic analyses were used to analyze bone formation. Invitro analysis demonstrated that anti-BMP2 mAbs tethered BMP2 ligands that can activate the BMP receptors on hBMMSCs. The co-delivery system described herein, significantly enhanced hBMMSC-mediated osteogenesis, as confirmed by the presence of BMP signal pathway-activated osteoblast determinants Runx2 and ALP. Our results highlight the importance of engineering the microenvironment for stem cells, and particularly the value of presenting inductive signals for osteo-differentiation of hBMMSCs by tethering BMP ligands using mAbs. This strategy of engineering the microenvironment with captured BMP signals is a promising modality for repair and regeneration of craniofacial, axial and appendicular bone defects.

Original languageEnglish
Pages (from-to)6572-6579
Number of pages8
JournalBiomaterials
Volume34
Issue number28
DOIs
Publication statusPublished - Sep 2013
Externally publishedYes

Fingerprint

Monoclonal antibodies
Alginate
Tissue Engineering
Stem cells
Microspheres
Mesenchymal Stromal Cells
Encapsulation
Tissue engineering
Bone
Bone Marrow
Monoclonal Antibodies
Bone and Bones
Ligands
Osteogenesis
Stem Cells
Bone Morphogenetic Protein Receptors
Defects
Stem Cell Niche
Osteoblasts
alginic acid

Keywords

  • Alginate hydrogel
  • Anti-BMP2 monoclonal antibodies
  • Cells encapsulation
  • Mesenchymal stem cell-mediated bone regeneration

ASJC Scopus subject areas

  • Biomaterials
  • Bioengineering
  • Ceramics and Composites
  • Mechanics of Materials
  • Biophysics

Cite this

Co-encapsulation of anti-BMP2 monoclonal antibody and mesenchymal stem cells in alginate microspheres for bone tissue engineering. / Moshaverinia, Alireza; Ansari, Sahar; Chen, Chider; Xu, Xingtian; Akiyama, Kentaro; Snead, Malcolm L.; Zadeh, Homayoun H.; Shi, Songtao.

In: Biomaterials, Vol. 34, No. 28, 09.2013, p. 6572-6579.

Research output: Contribution to journalArticle

Moshaverinia, Alireza ; Ansari, Sahar ; Chen, Chider ; Xu, Xingtian ; Akiyama, Kentaro ; Snead, Malcolm L. ; Zadeh, Homayoun H. ; Shi, Songtao. / Co-encapsulation of anti-BMP2 monoclonal antibody and mesenchymal stem cells in alginate microspheres for bone tissue engineering. In: Biomaterials. 2013 ; Vol. 34, No. 28. pp. 6572-6579.
@article{dee28f24058c494395279efab78725f6,
title = "Co-encapsulation of anti-BMP2 monoclonal antibody and mesenchymal stem cells in alginate microspheres for bone tissue engineering",
abstract = "Recently, it has been shown that tethered anti-BMP2 monoclonal antibodies (mAbs) can trap BMP ligands and thus provide BMP inductive signals for osteo-differentiation of progenitor cells. The objectives of this study were to: (1) develop a co-delivery system based on murine anti-BMP2 mAb-loaded alginate microspheres encapsulating human bone marrow mesenchymal stem cells (hBMMSCs); and (2) investigate osteogenic differentiation of encapsulated stem cells in alginate microspheres invitro and invivo. Alginate microspheres of 1±0.1mm diameter were fabricated with 2×106 hBMMSCs per mL of alginate. Critical-size calvarial defects (5mm diameter) were created in immune-compromised mice and alginate microspheres preloaded with anti-BMP mAb encapsulating hBMMSCs were transplanted into defect sites. Alginate microspheres pre-loaded with isotype-matched non-specific antibody were used as the negative control. After 8 weeks, micro CT and histologic analyses were used to analyze bone formation. Invitro analysis demonstrated that anti-BMP2 mAbs tethered BMP2 ligands that can activate the BMP receptors on hBMMSCs. The co-delivery system described herein, significantly enhanced hBMMSC-mediated osteogenesis, as confirmed by the presence of BMP signal pathway-activated osteoblast determinants Runx2 and ALP. Our results highlight the importance of engineering the microenvironment for stem cells, and particularly the value of presenting inductive signals for osteo-differentiation of hBMMSCs by tethering BMP ligands using mAbs. This strategy of engineering the microenvironment with captured BMP signals is a promising modality for repair and regeneration of craniofacial, axial and appendicular bone defects.",
keywords = "Alginate hydrogel, Anti-BMP2 monoclonal antibodies, Cells encapsulation, Mesenchymal stem cell-mediated bone regeneration",
author = "Alireza Moshaverinia and Sahar Ansari and Chider Chen and Xingtian Xu and Kentaro Akiyama and Snead, {Malcolm L.} and Zadeh, {Homayoun H.} and Songtao Shi",
year = "2013",
month = "9",
doi = "10.1016/j.biomaterials.2013.05.048",
language = "English",
volume = "34",
pages = "6572--6579",
journal = "Biomaterials",
issn = "0142-9612",
publisher = "Elsevier BV",
number = "28",

}

TY - JOUR

T1 - Co-encapsulation of anti-BMP2 monoclonal antibody and mesenchymal stem cells in alginate microspheres for bone tissue engineering

AU - Moshaverinia, Alireza

AU - Ansari, Sahar

AU - Chen, Chider

AU - Xu, Xingtian

AU - Akiyama, Kentaro

AU - Snead, Malcolm L.

AU - Zadeh, Homayoun H.

AU - Shi, Songtao

PY - 2013/9

Y1 - 2013/9

N2 - Recently, it has been shown that tethered anti-BMP2 monoclonal antibodies (mAbs) can trap BMP ligands and thus provide BMP inductive signals for osteo-differentiation of progenitor cells. The objectives of this study were to: (1) develop a co-delivery system based on murine anti-BMP2 mAb-loaded alginate microspheres encapsulating human bone marrow mesenchymal stem cells (hBMMSCs); and (2) investigate osteogenic differentiation of encapsulated stem cells in alginate microspheres invitro and invivo. Alginate microspheres of 1±0.1mm diameter were fabricated with 2×106 hBMMSCs per mL of alginate. Critical-size calvarial defects (5mm diameter) were created in immune-compromised mice and alginate microspheres preloaded with anti-BMP mAb encapsulating hBMMSCs were transplanted into defect sites. Alginate microspheres pre-loaded with isotype-matched non-specific antibody were used as the negative control. After 8 weeks, micro CT and histologic analyses were used to analyze bone formation. Invitro analysis demonstrated that anti-BMP2 mAbs tethered BMP2 ligands that can activate the BMP receptors on hBMMSCs. The co-delivery system described herein, significantly enhanced hBMMSC-mediated osteogenesis, as confirmed by the presence of BMP signal pathway-activated osteoblast determinants Runx2 and ALP. Our results highlight the importance of engineering the microenvironment for stem cells, and particularly the value of presenting inductive signals for osteo-differentiation of hBMMSCs by tethering BMP ligands using mAbs. This strategy of engineering the microenvironment with captured BMP signals is a promising modality for repair and regeneration of craniofacial, axial and appendicular bone defects.

AB - Recently, it has been shown that tethered anti-BMP2 monoclonal antibodies (mAbs) can trap BMP ligands and thus provide BMP inductive signals for osteo-differentiation of progenitor cells. The objectives of this study were to: (1) develop a co-delivery system based on murine anti-BMP2 mAb-loaded alginate microspheres encapsulating human bone marrow mesenchymal stem cells (hBMMSCs); and (2) investigate osteogenic differentiation of encapsulated stem cells in alginate microspheres invitro and invivo. Alginate microspheres of 1±0.1mm diameter were fabricated with 2×106 hBMMSCs per mL of alginate. Critical-size calvarial defects (5mm diameter) were created in immune-compromised mice and alginate microspheres preloaded with anti-BMP mAb encapsulating hBMMSCs were transplanted into defect sites. Alginate microspheres pre-loaded with isotype-matched non-specific antibody were used as the negative control. After 8 weeks, micro CT and histologic analyses were used to analyze bone formation. Invitro analysis demonstrated that anti-BMP2 mAbs tethered BMP2 ligands that can activate the BMP receptors on hBMMSCs. The co-delivery system described herein, significantly enhanced hBMMSC-mediated osteogenesis, as confirmed by the presence of BMP signal pathway-activated osteoblast determinants Runx2 and ALP. Our results highlight the importance of engineering the microenvironment for stem cells, and particularly the value of presenting inductive signals for osteo-differentiation of hBMMSCs by tethering BMP ligands using mAbs. This strategy of engineering the microenvironment with captured BMP signals is a promising modality for repair and regeneration of craniofacial, axial and appendicular bone defects.

KW - Alginate hydrogel

KW - Anti-BMP2 monoclonal antibodies

KW - Cells encapsulation

KW - Mesenchymal stem cell-mediated bone regeneration

UR - http://www.scopus.com/inward/record.url?scp=84879464132&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84879464132&partnerID=8YFLogxK

U2 - 10.1016/j.biomaterials.2013.05.048

DO - 10.1016/j.biomaterials.2013.05.048

M3 - Article

C2 - 23773817

AN - SCOPUS:84879464132

VL - 34

SP - 6572

EP - 6579

JO - Biomaterials

JF - Biomaterials

SN - 0142-9612

IS - 28

ER -